NIH-funded research R03 grant

Investigating how nanoscale oligomers affect cell membranes in Huntington's disease

Official title: Nanoscopic Membrane Modulations Induced by Nanoscale Oligomers

Funded at University of South Florida · NIH-10790511 · Data updated 2026-11-12

This study is looking at how tiny clumps of a faulty protein related to Huntington's disease affect brain cells, with the hope of finding ways to protect those cells and improve treatment options for patients.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of South Florida
NIH-funded
Lab location1 site (Tampa, United States)
Project startSeptember 8, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$141,650
NIH project number1R03NS135210-01
Project IDNIH-10790511 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Huntington's disease, particularly those experiencing early to moderate symptoms.

Less likely to help

Patients with advanced Huntington's disease or those without a confirmed diagnosis may not benefit from this research.

What this research studies

This research focuses on understanding the role of nanoscale oligomers of the mutant huntingtin protein in Huntington's disease, a severe neurodegenerative disorder. The study aims to explore how these oligomers interact with cell membranes, potentially leading to cellular dysfunction and neuronal death. By examining the lipid specificity of these interactions, the research seeks to uncover why certain cells are more vulnerable to amyloid toxicity than others. Patients may benefit from insights that could lead to targeted therapies aimed at protecting neurons from damage caused by these oligomers.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that protect neurons in Huntington's disease.

How similar studies have gone: Previous research has shown promising results in understanding amyloid interactions with cell membranes, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of South Florida
    Tampa, United States
    Active

Researchers

  • Principal investigator: Pan, Jianjun — University of South Florida
  • Study coordinator: Pan, Jianjun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.